{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:47:31Z","timestamp":1790390851896,"version":"4.1.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1053\/j.ajkd.2010.02.340","type":"journal-article","created":{"date-parts":[[2010,4,5]],"date-time":"2010-04-05T04:20:11Z","timestamp":1270441211000},"page":"773-799","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":220,"title":["KDOQI US Commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD\u2013Mineral and Bone Disorder (CKD-MBD)"],"prefix":"10.1053","volume":"55","author":[{"given":"Katrin","family":"Uhlig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Berns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Kestenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary B.","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart M.","family":"Sprague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Goldfarb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2010.02.340_bib1","first-page":"S1","article-title":"KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","volume":"113","year":"2009","journal-title":"Kidney Int Suppl"},{"issue":"4","key":"10.1053\/j.ajkd.2010.02.340_bib2","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1111\/j.1523-1755.2004.00894.x","article-title":"The burden of kidney disease: improving global outcomes","volume":"66","author":"Eknoyan","year":"2004","journal-title":"Kidney Int"},{"issue":"11","key":"10.1053\/j.ajkd.2010.02.340_bib3","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"issue":"7454","key":"10.1053\/j.ajkd.2010.02.340_bib4","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"issue":"12","key":"10.1053\/j.ajkd.2010.02.340_bib5","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1038\/sj.ki.5001875","article-title":"Grading evidence and recommendations for clinical practice guidelines in nephrology","volume":"70","author":"Uhlig","year":"2006","journal-title":"Kidney Int"},{"issue":"7652","key":"10.1053\/j.ajkd.2010.02.340_bib6","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/bmj.39493.646875.AE","article-title":"Going from evidence to recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"7","key":"10.1053\/j.ajkd.2010.02.340_bib7","doi-asserted-by":"crossref","first-page":"563","DOI":"10.7326\/0003-4819-148-7-200804010-00021","article-title":"Guideline adaptation: an appealing alternative to de novo guideline development","volume":"148","author":"Fervers","year":"2008","journal-title":"Ann Intern Med"},{"issue":"suppl 3","key":"10.1053\/j.ajkd.2010.02.340_bib8","first-page":"S1","article-title":"K\/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease","volume":"42","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"suppl 2","key":"10.1053\/j.ajkd.2010.02.340_bib9","first-page":"S1","article-title":"KDOQI Clinical Practice Guideline for Nutrition in Children With CKD: 2008 update","volume":"53","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"187","key":"10.1053\/j.ajkd.2010.02.340_bib10","first-page":"49923","article-title":"End-stage renal disease prospective payment system","volume":"74","year":"2009","journal-title":"Fed Regist"},{"issue":"2","key":"10.1053\/j.ajkd.2010.02.340_bib11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1053\/j.ajkd.2009.12.005","article-title":"The 2009 proposed rule for prospective ESRD payment: historical perspectives and public policies\u2014bundle up!","volume":"55","author":"Weiner","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2010.02.340_bib12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/j.ajkd.2009.12.004","article-title":"The 2009 proposed rule for prospective ESRD payment: perspectives from a large dialysis organization","volume":"55","author":"Nissenson","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2010.02.340_bib13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/j.ajkd.2009.12.007","article-title":"The 2009 proposed rule for prospective ESRD payment: perspectives from a medium-sized dialysis organization","volume":"55","author":"Moran","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2010.02.340_bib14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1053\/j.ajkd.2009.12.006","article-title":"The 2009 proposed rule for prospective ESRD payment: perspectives from a not-for-profit small dialysis organization","volume":"55","author":"Sadler","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2010.02.340_bib15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1053\/j.ajkd.2009.12.009","article-title":"The 2009 proposed rule for prospective ESRD payment: perspectives from a for-profit small dialysis organization","volume":"55","author":"Bhat","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2010.02.340_bib16","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1053\/j.ajkd.2009.12.008","article-title":"The 2009 proposed rule for prospective ESRD payment: perspectives from the forum of ESRD Networks","volume":"55","author":"Kristensen","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2010.02.340_bib17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0022-3476(80)80479-3","article-title":"Early diagnosis of juvenile renal osteodystrophy","volume":"97","author":"Norman","year":"1980","journal-title":"J Pediatr"},{"issue":"8","key":"10.1053\/j.ajkd.2010.02.340_bib18","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1681\/ASN.2007040449","article-title":"Pitfalls of measuring total blood calcium in patients with CKD","volume":"19","author":"Gauci","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2010.02.340_bib19","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1681\/ASN.V73506","article-title":"Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients","volume":"7","author":"Urena","year":"1996","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2010.02.340_bib20","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1093\/ndt\/13.9.2294","article-title":"Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients","volume":"13","author":"Coen","year":"1998","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1053\/j.ajkd.2010.02.340_bib21","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/ki.2008.248","article-title":"High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death","volume":"74","author":"Blayney","year":"2008","journal-title":"Kidney Int"},{"issue":"11","key":"10.1053\/j.ajkd.2010.02.340_bib22","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1681\/ASN.2008010014","article-title":"Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients","volume":"19","author":"Regidor","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2010.02.340_bib23","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5001514","article-title":"Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients","volume":"70","author":"Kalantar-Zadeh","year":"2006","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2010.02.340_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2010.02.340_bib25","doi-asserted-by":"crossref","unstructured":"Urena P, Ferreira A, Kung VT, et al. Serum pyridinoline as a specific marker of collagen breakdown and bone metabolism in hemodialysis patients. J Bone Miner Res. 11995;0(6):932-939.","DOI":"10.1002\/jbmr.5650100614"},{"issue":"4","key":"10.1053\/j.ajkd.2010.02.340_bib26","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jocd.2009.06.001","article-title":"25-Hydroxyvitamin D measurement, 2009: a review for clinicians","volume":"12","author":"Binkley","year":"2009","journal-title":"J Clin Densitometry"},{"issue":"4","key":"10.1053\/j.ajkd.2010.02.340_bib27","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1440-1797.2009.01131.x","article-title":"Review article: chronic kidney disease-mineral bone disorder: have we got the assays right?","volume":"14","author":"Zidehsarai","year":"2009","journal-title":"Nephrology"},{"issue":"suppl 2","key":"10.1053\/j.ajkd.2010.02.340_bib28","doi-asserted-by":"crossref","first-page":"V11","DOI":"10.1359\/jbmr.07s219","article-title":"Contemporary diagnosis and treatment of vitamin D-related disorders","volume":"22","author":"Jones","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1053\/j.ajkd.2010.02.340_bib29","doi-asserted-by":"crossref","first-page":"1080S","DOI":"10.1093\/ajcn\/87.4.1080S","article-title":"Vitamin D deficiency: a worldwide problem with health consequences","volume":"87","author":"Holick","year":"2008","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"10.1053\/j.ajkd.2010.02.340_bib30","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1525-139X.2005.18402.x","article-title":"Vitamin D for health and in chronic kidney disease","volume":"18","author":"Holick","year":"2005","journal-title":"Semin Dial"},{"key":"10.1053\/j.ajkd.2010.02.340_bib31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-0-387-77574-6_3","article-title":"Vitamin D status and cancer incidence and mortality","volume":"624","author":"Giovannucci","year":"2008","journal-title":"Adv Exp Med Biol"},{"issue":"8","key":"10.1053\/j.ajkd.2010.02.340_bib32","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/sj.ki.5002451","article-title":"Vitamin D levels and early mortality among incident hemodialysis patients","volume":"72","author":"Wolf","year":"2007","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ajkd.2010.02.340_bib33","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/ajcn\/85.6.1586","article-title":"Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial","volume":"85","author":"Lappe","year":"2007","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"10.1053\/j.ajkd.2010.02.340_bib34","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2215\/CJN.01150308","article-title":"Vitamin D and kidney disease","volume":"3","author":"Al-Badr","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2010.02.340_bib35","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.ajkd.2009.04.036","article-title":"Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial","volume":"54","author":"Fishbane","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.ajkd.2010.02.340_bib36","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1111\/j.1523-1755.2005.00755.x","article-title":"Antiproteinuric effect of oral paricalcitol in chronic kidney disease","volume":"68","author":"Agarwal","year":"2005","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ajkd.2010.02.340_bib37","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","article-title":"Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy","volume":"349","author":"Teng","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.ajkd.2010.02.340_bib38","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/jn\/136.4.1117","article-title":"Critique of the considerations for establishing the tolerable upper intake level for vitamin D: critical need for revision upwards","volume":"136","author":"Vieth","year":"2006","journal-title":"J Nutr"},{"issue":"1","key":"10.1053\/j.ajkd.2010.02.340_bib39","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/ajcn\/77.1.204","article-title":"Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol","volume":"77","author":"Heaney","year":"2003","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"10.1053\/j.ajkd.2010.02.340_bib40","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/ajcn\/68.4.854","article-title":"Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2","volume":"68","author":"Trang","year":"1998","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"10.1053\/j.ajkd.2010.02.340_bib41","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2010.02.340_bib42","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1053\/j.ajkd.2005.08.013","article-title":"The Kidney Disease Outcomes Quality Initiative (KDOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients","volume":"46","author":"Noordzij","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2010.02.340_bib43","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/ndt\/gfh734","article-title":"Do not be misguided by guidelines: the calcium x phosphate product can be a Trojan horse","volume":"20","author":"Ketteler","year":"2005","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1053\/j.ajkd.2010.02.340_bib44","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/sj.ki.5002412","article-title":"The fallacy of the calcium-phosphorus product","volume":"72","author":"O'Neill","year":"2007","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2010.02.340_bib45","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","article-title":"Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and parathyroid hormone: the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"52","author":"Tentori","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2010.02.340_bib46","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ki.2009.374","article-title":"Parathyroid hormone measurement in CKD","volume":"77","author":"Souberbielle","year":"2010","journal-title":"Kidney Int"},{"issue":"1-2","key":"10.1053\/j.ajkd.2010.02.340_bib47","first-page":"21","article-title":"Evolution of the parathyroid hormone (PTH) assay\u2014importance of circulating PTH immunoheterogeneity and of its regulation","volume":"51","author":"Gao","year":"2005","journal-title":"Clin Lab"},{"issue":"2","key":"10.1053\/j.ajkd.2010.02.340_bib48","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.ki.5001606","article-title":"Inter-method variability in PTH measurement: implication for the care of CKD patients","volume":"70","author":"Souberbielle","year":"2006","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ajkd.2010.02.340_bib49","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1053\/j.ajkd.2008.01.017","article-title":"Variation in serum and plasma PTH levels in second-generation assays in hemodialysis patients: a cross-sectional study","volume":"51","author":"Joly","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2010.02.340_bib50","unstructured":"Cavalier E, Rozet E, Gadisseur R, et al. Measurement uncertainty of 25-OH vitamin D determination with different commercially available kits: impact on the clinical cut offs [published online ahead of print September 9, 2009]. Osteoporos Int. doi 10.1007\/s00198-009-1052-5."},{"issue":"11","key":"10.1053\/j.ajkd.2010.02.340_bib51","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1359\/jbmr.060803","article-title":"25-Hydroxyvitamin D deficiency and diabetes predict reduced BMD in patients with chronic kidney disease","volume":"21","author":"Elder","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1053\/j.ajkd.2010.02.340_bib52","doi-asserted-by":"crossref","first-page":"6746","DOI":"10.1053\/j.ajkd.2007.02.264","article-title":"Low bone mineral density and fractures in long-term hemodialysis patients: a meta-analysis","volume":"49","author":"Jamal","year":"2007","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2010.02.340_bib53","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1359\/jbmr.060105","article-title":"Cortical pQCT measures are associated with fractures in dialysis patients","volume":"21","author":"Jamal","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1053\/j.ajkd.2010.02.340_bib54","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1053\/ajkd.2000.19093","article-title":"Parathormone secretion in peritoneal dialysis patients with adynamic bone disease","volume":"36","author":"Carmen","year":"2000","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2010.02.340_bib55","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0272-6386(03)00197-5","article-title":"Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients","volume":"41","author":"Bervoets","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2010.02.340_bib56","doi-asserted-by":"crossref","first-page":"284","DOI":"10.5414\/CNP63284","article-title":"New worldwide trends in presentation of renal osteodystrophy and its relationship to parathyroid hormone levels","volume":"63","author":"Gal-Moscovici","year":"2005","journal-title":"Clin Nephrol"},{"issue":"20","key":"10.1053\/j.ajkd.2010.02.340_bib57","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.ajkd.2010.02.340_bib58","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0735-1097(01)01781-8","article-title":"Cardiac calcification in adult hemodialysis patients","volume":"39","author":"Raggi","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.ajkd.2010.02.340_bib59","unstructured":"Uhlig K. There is no practical utility in routinely screening dialysis patients for vascular calcification. Semin Dial., in press."},{"issue":"8","key":"10.1053\/j.ajkd.2010.02.340_bib60","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2010.02.340_bib61","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1523-1755.2005.00185.x","article-title":"Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study","volume":"67","author":"Young","year":"2005","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2010.02.340_bib62","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1542-4758.2007.00190.x","article-title":"Association of mineral metabolism factors with all-cause and cardiovascular mortality in hemodialysis patients: the Japan Dialysis Outcomes and Practice Patterns Study","volume":"11","author":"Kimata","year":"2007","journal-title":"Hemodial Int"},{"issue":"2","key":"10.1053\/j.ajkd.2010.02.340_bib63","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2004070602","article-title":"Serum phosphate levels and mortality risk among people with chronic kidney disease","volume":"16","author":"Kestenbaum","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2010.02.340_bib64","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1053\/j.ajkd.2005.05.025","article-title":"Relationship of phosphorus and calcium-phosphorus product with mortality in CKD","volume":"46","author":"Menon","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.ajkd.2010.02.340_bib65","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2215\/CJN.00290109","article-title":"Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients","volume":"4","author":"Chiu","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2010.02.340_bib66","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0272-6386(12)80882-1","article-title":"Calcium and phosphorus fluxes during hemodialysis with low calcium dialysate","volume":"18","author":"Hou","year":"1991","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.ajkd.2010.02.340_bib67","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/ki.1993.92","article-title":"Calcium kinetics and the long-term effects of lowering dialysate calcium concentration","volume":"43","author":"Argiles","year":"1993","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2010.02.340_bib68","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1053\/j.jrn.2005.10.006","article-title":"Calcium exposure and removal in chronic hemodialysis patients","volume":"16","author":"Sigrist","year":"2006","journal-title":"J Ren Nutr"},{"issue":"2","key":"10.1053\/j.ajkd.2010.02.340_bib69","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000245924","article-title":"Calcium balance in dialysis is best managed by adjusting dialysate calcium guided by kinetic modeling of the interrelationship between calcium intake, dose of vitamin D analogues and the dialysate calcium concentration","volume":"29","author":"Gotch","year":"2010","journal-title":"Blood Purif"},{"issue":"9","key":"10.1053\/j.ajkd.2010.02.340_bib70","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1097\/01.ASN.0000083044.42480.C1","article-title":"Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate calcium concentration","volume":"14","author":"Al-Hejaili","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2010.02.340_bib71","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1542-4758.2007.00172.x","article-title":"Comparison between different dialysate calcium concentrations in nocturnal hemodialysis","volume":"11","author":"Toussaint","year":"2007","journal-title":"Hemodial Int"},{"issue":"4","key":"10.1053\/j.ajkd.2010.02.340_bib72","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1053\/j.ajkd.2009.06.004","article-title":"Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials","volume":"54","author":"Navaneethan","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.ajkd.2010.02.340_bib73","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2215\/CJN.06080809","article-title":"Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease","volume":"5","author":"Kalantar-Zadeh","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2010.02.340_bib74","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/j.ajkd.2009.01.269","article-title":"Dietary phosphorus restriction in dialysis patients: potential impact of processed meat, poultry, and fish products as protein sources","volume":"54","author":"Sherman","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1053\/j.ajkd.2010.02.340_bib75","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.2215\/CJN.02830409","article-title":"Phosphorus and potassium content of enhanced meat and poultry products: implications for patients who receive dialysis","volume":"4","author":"Sherman","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1053\/j.ajkd.2010.02.340_bib76","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1001\/jama.298.11.1291","article-title":"Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial","volume":"298","author":"Culleton","year":"2007","journal-title":"JAMA"},{"issue":"4","key":"10.1053\/j.ajkd.2010.02.340_bib77","article-title":"Vitamin D compounds for people with chronic kidney disease not requiring dialysis","author":"Palmer","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"19","key":"10.1053\/j.ajkd.2010.02.340_bib78","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2010.02.340_bib79","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1359\/JBMR.050817","article-title":"Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials","volume":"20","author":"Miller","year":"2005","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1053\/j.ajkd.2010.02.340_bib80","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1359\/jbmr.070112","article-title":"Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial","volume":"22","author":"Jamal","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1053\/j.ajkd.2010.02.340_bib81","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1681\/ASN.2007050555","article-title":"The effect of raloxifene treament in postmenopausal women with CKD","volume":"19","author":"Ishani","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2010.02.340_bib82","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/ndt\/gfm217","article-title":"Bisphosphonates in the renal patient","volume":"22","author":"Cunningham","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2010.02.340_bib83","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003264.pub2","article-title":"Growth hormone for children with chronic kidney disease","volume":"3","author":"Vimalachandra","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1053\/j.ajkd.2010.02.340_bib84","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000110875","article-title":"Abnormal bone and mineral metabolism in kidney transplant patients\u2014a review","volume":"28","author":"Sprague","year":"2008","journal-title":"Am J Nephrol"},{"issue":"8","key":"10.1053\/j.ajkd.2010.02.340_bib85","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJM199108223250804","article-title":"Rapid loss of vertebral mineral density after renal transplantation","volume":"325","author":"Julian","year":"1991","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.ajkd.2010.02.340_bib86","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1399-3046.2004.00191.x","article-title":"Treatment of osteopenia and osteoporosis in renal transplant children and adolescents","volume":"8","author":"El-Husseini","year":"2004","journal-title":"Pediatr Transplant"},{"issue":"8","key":"10.1053\/j.ajkd.2010.02.340_bib87","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1001\/jama.282.8.771","article-title":"Users' guides to the medical literature: XIX","volume":"282","author":"Bucher","year":"1999","journal-title":"JAMA"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638610004890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638610004890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:53:36Z","timestamp":1759456416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638610004890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":87,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0272638610004890"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2010.02.340","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KDOQI US Commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD\u2013Mineral and Bone Disorder (CKD-MBD)","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2010.02.340","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}